Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 158, Issue 2, 1998, Pages 437-443

  Zhu, Guang Fa ^b   Sun, Bo ^a   Niu, Shan Fu ^b   Cai, Ying Yun ^b   Lin, Ke ^b   Lindwall, Robert ^b   Robertson, Bengt ^b  

^a FUDAN UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHEMOGLOBIN; NITRATE; NITRIC OXIDE; NITRITE; OLEIC ACID; PHOSPHATIDYLCHOLINE; PROTEIN; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD OXYGENATION; CONTROLLED STUDY; FUNCTIONAL RESIDUAL CAPACITY; INHALATIONAL DRUG ADMINISTRATION; INTRATRACHEAL DRUG ADMINISTRATION; LUNG ALVEOLUS SURFACE TENSION; LUNG COMPLIANCE; LUNG FUNCTION; LUNG LAVAGE; LUNG MECHANICS; LUNG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RESPIRATORY DISTRESS;

EID: 15444360963     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.158.2.9711107     Document Type: Article

References (34)

1. Hallman, M., R. G., Spragg, J. H. Harrell, K. M. Moser, and L. Gluck. 1982. Evidence of lung surfactant abnormality in respiratory failure: study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J. Clin. Invest. 70:673-683.
2. Bernard, G. R., A. Artigas, K. L. Brigham, J. Carlet, K. Falke, L. Hudson, M. Lamy, J. R. Legall, A. Morris, and R. Spragg. 1944. The American-European Consensus Conference on ARDS, definition, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149:818-824.
3. Baughman, R. P., K. L. Gunther, M. C. Rashkin, D. A. Keeton, and E. D. Pattishall. 1996. Changes in the inflammatory responses of the lung during acute respiratory distress syndrome: prognostic indicators. Am. J. Respir. Crit. Care Med. 154:76-81.
4. Wilson, D. F., J. H. Jiao, L. A. Bauman, A. Zaritsky, H. Craft, K. Dockery, D. Conrad, and H. Dalton. 1996. Calf's lung surfactant extract in acute hypoxemic respiratory failure in children. Crit. Care Med. 24: 1316-1322.
5. Gregory, T. J., K. P. Steinberg, R. G. Spragg, J. E. Gadek, T. M. Hyers, W. J. Longmore, M. A., Moxley, G. Z. Cai, R. D. Hite, R. M. Smith, L. D. Hudson, C. Crim, P. Newton, B. R. Mitchell, and A. Gold. 1997. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 155:1309-1315.
6. The Neonatal Inhaled Nitric Oxide Study Group. 1997. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N. Engl. J. Med. 336:597-604.
7. Rossaint, R., K. F. Falke, F. Lopez, K. Slama, U. Pison, and W. M. Zapol. 1993. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 328:399-405.
8. Gerlach, H., D. Pappert, K. Lewandowski, R. Rossiant, and K. J. Falke. 1993. Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med. 19:443-449.
9. Zapol, W. M., S. Rimar, N. Gillis, M. Marietta, and C. H. Bosken. 1994. Nitric oxide and the lung. Am. J. Respir. Crit. Care Med. 149:1375-1380.
10. Krafft, P., P. Fridrich, R. D. Fitzgerald, D. Koc, and H. Steltzer. 1996. Effectiveness of nitric oxide inhalation in septic ARDS. Chest 109: 486-493.
11. Day, R. W., M. Guarin, J. M. Lynch, D. D. Vernon, and J. M. Dean. 1996. Inhaled nitric oxide in children with severe lung disease: results of acute and prolonged therapy with two concentrations. Crit. Care Med. 24:215-221.
12. Gaston, B., J. M. Drazen, J. Loscalzo, and J. S. Stamler. 1994. The biology of nitrogen oxides in the airways. Am. J. Respir. Crit. Care Med. 149:538-551.
13. Frostell, C. G., M. D. Fratacci, J. C. Wain, R. Jones, and W. M. Zapol. 1991. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83:2038-2047.
14. Walti, H., B. S. Polla, and M. Bachelet. 1997. Modified natural porcine surfactant inhibits superoxide anions and proinflammatory mediators released by resting and stimulated human monocytes. Pediatr. Res. 41:114-119.
15. Kinsella, J. P., T. A. Parker, H. Galan, B. C. Sheridan, A. C. Halbower, and S. H. Abman. 1997. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr. Res. 41:457-463.
16. Bartlett, G. B. 1959. Phosphorous assay in column chromatography. J. Biol. Chem. 234:466-468.
17. Mason, R. J., J. Nellenbogen, and J. A. Clements. 1976. Isolation of disaturated phosphatidylcholine with osmium tetroxide. J. Lipid Res. 17:281-284.
18. Hall, S. B., A. R. Venkitaraman, R. W. Hyde, and R. H. Notter. 1990. Altered function of pulmonary surfactant in fatty acid lung injury. J. Appl. Physiol. 69:1143-1149.
19. Skimming, J. W., V. G. DeMarco, and S. Cassin. 1995. The effects of nitric oxide inhalation on the pulmonary circulation of preterm lambs. Pediatr. Res. 37:35-40.
20. Sun B., T. Curstedt, and B. Robertson. 1996. Exogenous surfactant improves ventilation efficiency and alveolar expansion in rats with meconium aspiration. Am. J. Respir. Crit. Care Med. 154:764-770.
21. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
22. Sun, B., T. Curstedt, and B. Robertson. 1996. Long-term cycling of surfactant films in Wilhelmy balance. Reprod. Fertil. Dev. 8:173-181.
23. Sun, B., E. Herting, T. Curstedt, and B. Robertson. 1994. Exogenous surfactant improves lung compliance and oxygenation in adult rats with meconium aspiration. J. Appl. Physiol. 77:1961-1971.
24. Shi, Y., H. Q. Li, C. K. Shen, J. H. Wang, J. Pan, S. W. Qin, and R. Liu. 1993. Association between protective efficacy of antibodies to tumor necrosis factor and suppression of nitric oxide production in neonatal rats with fatal infection. Pediatr. Res. 34:345-348.
25. Hegesh, E., N. Gruener, S. Cohen, R. Bochkovsky, and H. I. Shuval. 1970. A sensitive micromethod for the determination of methemoglobin in blood. Clin. Chim. Acta 30:679-682.
26. Ennema, J. J., T. Kobayashi, B. Robertson, and T. Curstedt. 1988. Inactivation of exogenous surfactant in experimental respiratory failure induced by hyperoxia. Acta Anaesthesiol. Scand. 32:665-671.
27. Hall, S. B., R. W. Hyde, and R. H. Notter. 1994. Changes in subphase aggregates in rabbits injured by free fatty acid. Am. J. Respir. Crit. Care Med. 149:1099-1106.
28. Putensen, C., J. Rasanen, F. A. Lopez, and J. B. Downs. 1994. Continuous positive airway pressure modulates effect of inhaled nitric oxide on the ventilation-perfusion distributions in canine lung injury. Chest 106:1563-1569.
29. Zucker, A. R., B. A. Holm, G. P. Crawford, K. Ridge, L. D. H. Wood, and I. Sznajder. 1992. PEEP is necessary for exogenous surfactant to reduce pulmonary edema in canine aspiration pneumonitis. J. Appl. Physiol. 73:679-686.
30. Shah, N. S., D. K. Nakayama, T. D. Jacob, I. Nishio, T. Imai, T. R. Billiar, R. Exler, S. A. Yousem, E. K. Motoyama, and A. B. Peitzman. 1997. Efficacy of inhaled nitric oxide in oleic acid-induced acute lung injury. Crit. Care Med. 25:153-158.
31. Leeman, M., V. Z. de Beyl, E. Gilbert, C. Melot, and R. Naeije. 1993. Is nitric oxide released in oleic acid lung injury? J. Appl. Physiol. 74:650-654.
32. Finer, N. N., P. C. Etches, B. Kamstra, A. J. Tierney, A. Peliowski, and C. A. Ryan. 1994. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J. Pediatr. 124:302-308.
33. Roberts, J. D., P. Lang, L. M. Bigatello, G. J. Vlahakes, and W. M. Zapol. 1993. Inhaled nitric oxide in congenital heart disease. Circulation 87:447-453.
34. Yu, X. Q., B. A. Feet, A. Moen, T. Curstedt, and O. D. Saugstad. 1997. Nitric oxide contributes to surfactant-induced vasodilation in surfactant-depleted newborn piglets. Pediatr. Res. 42:151-156.